NUVB - Nuvation Bio Inc. -  [ ]

Ticker Details
Nuvation Bio Inc.
IPO Date: August 24, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $2.43B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.16 | 3.61%
Avg Daily Range (30 D): $0.21 | 3.31%
Avg Daily Range (90 D): $0.19 | 3.49%
Institutional Daily Volume
Avg Daily Volume: 2.1M
Avg Daily Volume (30 D): 5.53M
Avg Daily Volume (90 D): 5.35M
Trade Size
Avg Trade Size (Sh.): 205
Avg Trade Size (Sh.) (30 D): 164
Avg Trade Size (Sh.) (90 D): 185
Institutional Trades
Total Institutional Trades: 1,058
Avg Institutional Trade: $2.16M
Avg Institutional Trade (30 D): $2.21M
Avg Institutional Trade (90 D): $1.93M
Avg Institutional Trade Volume: .44M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.76M
Avg Closing Trade (30 D): $3.03M
Avg Closing Trade (90 D): $2.84M
Avg Closing Volume: 523.95K
 
News
Jun 29, 2026 @ 11:19 PM
Nuvation Bio Stock Is Up 190% Despite Recent Press...
Source: Jonathan Ponciano
Jun 17, 2026 @ 4:01 PM
Veteran Pharma VC Insider Buys 25,000 Nuvation Bio...
Source: Brendan Coffey
Apr 13, 2026 @ 4:04 AM
Insider Sells 200K Shares of Biotech Company Nuvat...
Source: Pamela Kock
Mar 21, 2026 @ 9:15 PM
NUVB Investors Have Opportunity to Join Nuvation B...
Source: Schall Law Firm
Mar 10, 2026 @ 7:52 PM
INVESTOR ALERT: Pomerantz Law Firm Reminds Investo...
Source: Pomerantz Llp
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-.44 $-.18 $.02
Diluted EPS $-.44 $-.18 $.01
Revenue $169.9M $31.69M $83.23M
Gross Profit
Net Income / Loss $-149.83M $-62.84M $5.4M
Operating Income / Loss $-137.63M $-51.04M $3.88M
Cost of Revenue
Net Cash Flow $10.63M $133.21M $-38.7M
PE Ratio